kymriah
novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - iné antineoplastické látky - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.
lekoklar 250 mg/5 ml granulát na perorálnu suspenziu
sandoz pharmaceuticals d.d., slovinsko - klaritromycín - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)
lekoklar 125 mg/5 ml granulát na perorálnu suspenziu
sandoz pharmaceuticals d.d., slovinsko - klaritromycín - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)
lekoklar 250 mg filmom obalené tablety
sandoz pharmaceuticals d.d., slovinsko - klaritromycín - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)
lekoklar 500 mg filmom obalené tablety
sandoz pharmaceuticals d.d., slovinsko - klaritromycín - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)
dailiport 5 mg
sandoz pharmaceuticals d.d., slovinsko - takrolimus - 59 - immunopraeparata
dailiport 3 mg
sandoz pharmaceuticals d.d., slovinsko - takrolimus - 59 - immunopraeparata
dailiport 1 mg
sandoz pharmaceuticals d.d., slovinsko - takrolimus - 59 - immunopraeparata
dailiport 0,5 mg
sandoz pharmaceuticals d.d., slovinsko - takrolimus - 59 - immunopraeparata
clarithromycin hameln 500 mg prášok na koncentrát na infúzny roztok
hameln pharma gmbh, nemecko - klaritromycín - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)